299 related articles for article (PubMed ID: 36600621)
21. Structure and Aggregation Mechanisms in Amyloids.
Almeida ZL; Brito RMM
Molecules; 2020 Mar; 25(5):. PubMed ID: 32155822
[TBL] [Abstract][Full Text] [Related]
22. Functional amyloids: interrelationship with other amyloids and therapeutic assessment to treat neurodegenerative diseases.
Som Chaudhury S; Das Mukhopadhyay C
Int J Neurosci; 2018 May; 128(5):449-463. PubMed ID: 29076790
[TBL] [Abstract][Full Text] [Related]
23. Amyloidogenesis: What Do We Know So Far?
Alraawi Z; Banerjee N; Mohanty S; Kumar TKS
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430450
[TBL] [Abstract][Full Text] [Related]
24. Autophagy Modulation as a Treatment of Amyloid Diseases.
Mputhia Z; Hone E; Tripathi T; Sargeant T; Martins R; Bharadwaj P
Molecules; 2019 Sep; 24(18):. PubMed ID: 31527516
[TBL] [Abstract][Full Text] [Related]
25. β-Barrels and Amyloids: Structural Transitions, Biological Functions, and Pathogenesis.
Sulatskaya AI; Kosolapova AO; Bobylev AG; Belousov MV; Antonets KS; Sulatsky MI; Kuznetsova IM; Turoverov KK; Stepanenko OV; Nizhnikov AA
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768745
[TBL] [Abstract][Full Text] [Related]
26. Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease.
Horvath I; Wittung-Stafshede P
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12473-12477. PubMed ID: 27791129
[TBL] [Abstract][Full Text] [Related]
27. Amyloid Cross-Seeding: Mechanism, Implication, and Inhibition.
Subedi S; Sasidharan S; Nag N; Saudagar P; Tripathi T
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335141
[TBL] [Abstract][Full Text] [Related]
28. Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation.
Zaman M; Khan AN; Wahiduzzaman ; Zakariya SM; Khan RH
Int J Biol Macromol; 2019 Aug; 134():1022-1037. PubMed ID: 31128177
[TBL] [Abstract][Full Text] [Related]
29. Peptide Amyloids in the Origin of Life.
Greenwald J; Kwiatkowski W; Riek R
J Mol Biol; 2018 Oct; 430(20):3735-3750. PubMed ID: 29890117
[TBL] [Abstract][Full Text] [Related]
30. Structural polymorphism and cytotoxicity of brain-derived β-amyloid extracts.
Al Adem K; Lee S
Protein Sci; 2023 May; 32(5):e4639. PubMed ID: 37051675
[TBL] [Abstract][Full Text] [Related]
31. Why are Functional Amyloids Non-Toxic in Humans?
Jackson MP; Hewitt EW
Biomolecules; 2017 Sep; 7(4):. PubMed ID: 28937655
[TBL] [Abstract][Full Text] [Related]
32. Amyloids, amorphous aggregates and assemblies of peptides - Assessing aggregation.
Juković M; Ratkaj I; Kalafatovic D; Bradshaw NJ
Biophys Chem; 2024 May; 308():107202. PubMed ID: 38382283
[TBL] [Abstract][Full Text] [Related]
33. Noncovalent, Electrostatic Interactions Induce Positively Cooperative Binding of Small Molecules to Alzheimer's and Parkinson's Disease-Related Amyloids.
Cifelli JL; Capule CC; Yang J
ACS Chem Neurosci; 2019 Feb; 10(2):991-995. PubMed ID: 30044911
[TBL] [Abstract][Full Text] [Related]
34. Formation of Heterotypic Amyloids: α-Synuclein in Co-Aggregation.
Bhasne K; Mukhopadhyay S
Proteomics; 2018 Nov; 18(21-22):e1800059. PubMed ID: 30216674
[TBL] [Abstract][Full Text] [Related]
35. Kinetic diversity of amyloid oligomers.
Dear AJ; Michaels TCT; Meisl G; Klenerman D; Wu S; Perrett S; Linse S; Dobson CM; Knowles TPJ
Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12087-12094. PubMed ID: 32414930
[TBL] [Abstract][Full Text] [Related]
36. Amyloid peptides and proteins in review.
Harrison RS; Sharpe PC; Singh Y; Fairlie DP
Rev Physiol Biochem Pharmacol; 2007; 159():1-77. PubMed ID: 17846922
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Pairs of Toxic and Nontoxic Misfolded Protein Oligomers Elucidates the Structural Determinants of Oligomer Toxicity in Protein Misfolding Diseases.
Limbocker R; Cremades N; Cascella R; Tessier PM; Vendruscolo M; Chiti F
Acc Chem Res; 2023 Jun; 56(12):1395-1405. PubMed ID: 37071750
[TBL] [Abstract][Full Text] [Related]
38. Amyloidogenic Peptides in Human Neuro-Degenerative Diseases and in Microorganisms: A Sorrow Shared Is a Sorrow Halved?
Endres K
Molecules; 2020 Feb; 25(4):. PubMed ID: 32093040
[TBL] [Abstract][Full Text] [Related]
39. Amyloids as Building Blocks for Macroscopic Functional Materials: Designs, Applications and Challenges.
Li J; Zhang F
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639037
[TBL] [Abstract][Full Text] [Related]
40. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
Kreutzer AG; Nowick JS
Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
